Managing Migraine: Medication Overuse Headache and Treatment with Eptinezumab.

Authors:
Limberg N.

Journal:
Pain Ther

Publication Year: 2023

DOI:
10.1007/s40122-023-00534-w

PMCID:
PMC10444718

PMID:
37347339

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pain Ther

Abbreviation: Pain Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Clinical Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Additional Effect of Extracorporeal Shockwave Therapy with Lidocaine Injection on Clinical and MRI …
Nambi G; Alghadier M; Eltayeb MM and 9 more (2024) - Transparency Score: 4/6
Efficacy of Transcutaneous Electrical Acupoint Stimulation on Chronic Postsurgical Pain After Video…
Chen S; Ding Y; Zhang X and 9 more (2024) - Transparency Score: 4/6
H-Wave<sup>®</sup> Device Stimulation for Chronic Low Back Pain: A Patient-Reported Outcome Measure…
Norwood SM; Han D; Gupta A. (2024) - Transparency Score: 3/6
Neuromodulation Techniques in Chronic Refractory Coccydynia: A Narrative Review.
Rahimibarghani S; Morgan R; Diaz JJ. (2024) - Transparency Score: 3/6
Percutaneous Stylomastoid Foramen Pulsed Radiofrequency Combined with Steroid Injection for Treatme…
Deng R; Wang R; Yao M and 1 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures Nicole Limberg reports payments for advisory boards from AbbVie, Eli Lilly, TEVA, and Lundbeck."

Evidence found in paper:

"Funding The development of this manuscript was supported funded by Lundbeck."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025